Upload
noma
View
71
Download
0
Tags:
Embed Size (px)
DESCRIPTION
MRCPsych addiction psychiatry seminar series. Policy, guidance, service structures and legal framework of addiction treatment Epidemiology of addictive disorder Psychological interventions Management of tobacco use and addiction Dr Stuart McLaren March 2010. - PowerPoint PPT Presentation
Citation preview
MRCPsych addiction psychiatry seminar series
• Policy, guidance, service structures and legal framework of addiction treatment
• Epidemiology of addictive disorder• Psychological interventions• Management of tobacco use and addiction
Dr Stuart McLaren March 2010
Policy, guidance, service structures and legal framework
UK drug policy
• 1998 Tackling drugs to build a better Britain – 10 year strategy
• 2002, updated 2006 Models of Care for drug misusers
• 2006 Models of Care for alcohol misusers• 2008 Drugs: protecting families and
communities – next 10 year strategy
UK Drug Strategy
• NTORS/effectiveness review/NICE• NTA/Healthcare commission• NDTMS• TOP• Harm reduction approach• Criminal justice initiatives
Harm reduction approach
Defines policies, programmes, services and activities (treatments) that work to reduce the:
• Health, social and economic harms to:• Individuals, communities, and societythat are associated with drug use.
Factors associated with harm
• Route of injection• Nature, extent and pattern of use• Prevalence of BBVs in IDUs population• Life style factors associated with use• Drug policy environment• Characteristics of healthcare environment
Specific health problems
• Drug overdose• HIV, hepatitis B & C• Bacterial infections, including TB• Fungal infections• Venous and arterial problems• Dental problems• Respiratory and cardiovascular promblems• Mental illness• Violence
Harm reductions approaches to injecting drug use
• Needle (-syringe) exchange programmes• Substitute prescribing treatment• HIV/AIDS related treatment• Hepatitis B vaccination• Hepatitis C testing• Information, advice and education
NICE guidance 2007
• Technology appraisals:-Methadone and buprenorphine for the management of opioid dependence (TAG 114)-Naltrexone for the management of opioid dependence (TAG 115)
NICE guidance 2007
• Clinical guidelines-Drug misuse: opioid detoxification-Drug misuse: psychosocial interventions
Department of Health guidelines 2007
Drug misuse and dependence: UK guidelines on clinical management ‘the orange book’
UK commissioning structure
National Treatment Agency
Drug (A) Action Teams
Providers
Structure of treatment services
• Residential rehabilitation houses• Inpatient units• Regional drug services• Specialist, statutory drug services• Shared care/primary care services• Non-statutory, street-level services• Self -help groups
Structure of treatment services
• Tier 4 residential • Tier 3 structured community based• Tier 2 open access (usually non-
statutory)• Tier 1 interface services
Home Office drug initiatives
• Police custody – drug testing, arrest referral schemes
• Courts and probation – drug monitoring, RoB, DRRs
• Prison – CARAT teams• Aftercare
Misuse of Drugs Act 1971 and Regulations 2001
• Class A – cocaine, ecstasy, heroin, LSD, methadone, Class B drugs injected
• Class B – amphetamines, barbiturates, codeine
• Class C – anabolic steroids, minor tranquillisers, cannabis
Misuse of Drugs Act – maximum penalties
possession trafficking
Class A 7 years + fine life + fine
Class B 5 years + fine 14 years + fine
Class C 2 years + fine 5 years + fine
Regulations
• Schedule 1 – no therapeutic value (cannabis,LSD)
• Schedule 2 & 3 – can be prescribed (heroin, amphetamine, temazepam)
• Schedule 4 – can be prescribed (mostly benzodiazepines)
• Schedule 5 – over the counter medications
Implications
Doctors can prescribe:AmphetaminesBarbituratesCocaine**Heroin**Methadone** need HO license to prescribe to ‘addicts’
Mental Health Act 1983
Part I application of Act
‘Nothing… above shall be construed as implying that a person may be dealt with under this Act as suffering from mental disorder….by reason of…dependence on alcohol or drugs’
Mental & behavioural disorders due to psychoactive substance
use
• F1x.4 withdrawal state with delirium• F1x.5 psychotic disorder• F1x.6 amnesic disorder• F1x.7 residual and late-onset psychotic
disorder